Article Text

Download PDFPDF
Original article
The TRPA1 ion channel is expressed in CD4+ T cells and restrains T-cell-mediated colitis through inhibition of TRPV1
  1. Samuel Bertin1,
  2. Yukari Aoki-Nonaka1,2,
  3. Jihyung Lee1,
  4. Petrus R de Jong1,
  5. Peter Kim1,
  6. Tiffany Han1,
  7. Timothy Yu1,
  8. Keith To1,
  9. Naoki Takahashi1,2,
  10. Brigid S Boland3,4,
  11. John T Chang3,4,
  12. Samuel B Ho3,5,
  13. Scott Herdman1,
  14. Maripat Corr1,
  15. Alessandra Franco6,
  16. Sonia Sharma7,
  17. Hui Dong3,
  18. Armen N Akopian8,
  19. Eyal Raz1
  1. 1Division of Rheumatology, Allergy & Immunology, Department of Medicine, University of California San Diego, La Jolla, California, USA
  2. 2Department of Oral Biological Science, Niigata University Graduate School of Medical and Dental Sciences, Chuo-ku, Niigata, Japan
  3. 3Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California, USA
  4. 4Inflammatory Bowel Disease Center, University of California San Diego, La Jolla, California, USA
  5. 5Division of Gastroenterology, Department of Medicine, VA San Diego Healthcare System, San Diego, California, USA
  6. 6Department of Pediatrics, University of California San Diego, La Jolla, California, USA
  7. 7La Jolla Institute for Allergy and Immunology, La Jolla, California, USA
  8. 8Department of Endodontics, UTHSCSA, San Antonio, Texas, USA
  1. Correspondence to Dr Eyal Raz, Professor of Medicine, Department of Medicine, UCSD, 9500 Gilman Drive, La Jolla, CA 92093-0663, USA; eraz{at} Dr Armen N. Akopian, Associate Professor, Department of Endodontics, UTHSCSA, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA; Akopian{at}


Objective Transient receptor potential ankyrin-1 (TRPA1) and transient receptor potential vanilloid-1 (TRPV1) are calcium (Ca2+)-permeable ion channels mostly known as pain receptors in sensory neurons. However, growing evidence suggests their crucial involvement in the pathogenesis of IBD. We explored the possible contribution of TRPA1 and TRPV1 to T-cell-mediated colitis.

Design We evaluated the role of Trpa1 gene deletion in two models of experimental colitis (ie, interleukin-10 knockout and T-cell-adoptive transfer models). We performed electrophysiological and Ca2+ imaging studies to analyse TRPA1 and TRPV1 functions in CD4+ T cells. We used genetic and pharmacological approaches to evaluate TRPV1 contribution to the phenotype of Trpa1−/− CD4+ T cells. We also analysed TRPA1 and TRPV1 gene expression and TRPA1+TRPV1+ T cell infiltration in colonic biopsies from patients with IBD.

Results We identified a protective role for TRPA1 in T-cell-mediated colitis. We demonstrated the functional expression of TRPA1 on the plasma membrane of CD4+ T cells and identified that Trpa1−/− CD4+ T cells have increased T-cell receptor-induced Ca2+ influx, activation profile and differentiation into Th1-effector cells. This phenotype was abrogated upon genetic deletion or pharmacological inhibition of the TRPV1 channel in mouse and human CD4+ T cells. Finally, we found differential regulation of TRPA1 and TRPV1 gene expression as well as increased infiltration of TRPA1+TRPV1+ T cells in the colon of patients with IBD.

Conclusions Our study indicates that TRPA1 inhibits TRPV1 channel activity in CD4+ T cells, and consequently restrains CD4+ T-cell activation and colitogenic responses. These findings may therefore have therapeutic implications for human IBD.

  • IBD

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.